Know Cancer

or
forgot password

Collection of Blood From Patients With Prostate Cancer


N/A
18 Years
N/A
Open (Enrolling by invite only)
Male
Prostate Cancer

Thank you

Trial Information

Collection of Blood From Patients With Prostate Cancer


Objectives:

To obtain blood samples from patients with prostate cancer for genotyping analyses.

Eligibility:

All patients seen in the NCI prostate cancer clinic are eligible.

Design:

Patients with a prior diagnosis of prostate cancer will be evaluated in the Medical Oncology
Clinic, NCI. Blood samples may be collected at the initial visit or at follow-up visits.
Genomic DNA and white blood cells will each be extracted from these samples to be utilized
for genotyping and establishment of individual cell lines. Genetic variance will be
correlated with prostate cancer prognosis (i.e. time from diagnosis to death) and prognostic
indicators (i.e. histological tumor grade). Healthy controls will not be compared and no
correlations will be made with prostate cancer susceptibility.

Inclusion Criteria


- INCLUSION CRITERIA:

Patients 18 years of age and older are eligible.

Patients with a diagnosis of prostate cancer are eligible.

EXCLUSION CRITERIA:

Children are not eligible.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

William D Figg, Pharm.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

070100

NCT ID:

NCT00923221

Start Date:

February 2007

Completion Date:

Related Keywords:

  • Prostate Cancer
  • Hormone-Refractory
  • Bone Metastases
  • Genome Analysis
  • Androgen Independent
  • Tissue
  • Genotyping
  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location

National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, Maryland  20892